title: ACIP immunization update.
abstract: Males ages 11 to 12 years should routinely receive quadrivalent vaccine against human papillomavirus; patients through age 59 years who have diabetes should receive HBV vaccine routinely.
authors.affiliation: Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, USA. dougco@email.arizona.edu
authors.forename: Doug
authors.initials: D
authors.lastname: Campos-Outcalt
mesh_terms: D000328:Adult; D026683:Advisory Committees; D000368:Aged; D001005:Anus Neoplasms / Q000517:prevention & control; D002278:Carcinoma in Situ / Q000517:prevention & control; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D003218:Condylomata Acuminata / Q000517:prevention & control; D004168:Diphtheria Toxoid; D005260:Female; D017325:Hepatitis B Vaccines; D053061:Herpes Zoster Vaccine; D006801:Humans; D007115:Immunization Schedule; D007252:Influenza Vaccines; D008297:Male; D022401:Meningococcal Vaccines; D008875:Middle Aged; D053918:Papillomavirus Vaccines; D010567:Pertussis Vaccine; D013745:Tetanus Toxoid; D014481:United States; D014611:Vaccination / Q000592:standards*; D018074:Vaccines, Conjugate; D055815:Young Adult
chemical_list: D004168:Diphtheria Toxoid; D017325:Hepatitis B Vaccines; D053061:Herpes Zoster Vaccine; D007252:Influenza Vaccines; D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines; D010567:Pertussis Vaccine; D013745:Tetanus Toxoid; D018074:Vaccines, Conjugate